All-Trans-Retinoic Acid and Pseudotumor Cerebri
- 1 January 1996
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 23 (5-6) , 437-442
- https://doi.org/10.3109/10428199609054851
Abstract
Pseudotumor cerebri or idiopathic intracranial hypertension is a neurological syndrome characterized by signs and symptoms of intracranial hypertension without clinical and radiological evidence of infective or space occupying lesions. Iatrogenic factors are frequent; in particular, cases of Pseudotumor cerebri associated with all-trans-retinoic acid treatment in acute promyelocyte leukemia (APL) have been frequently described in pediatric patients. We review the literature and give diagnostic and therapeutic guidelines.Keywords
This publication has 56 references indexed in Scilit:
- Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1993
- Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.Journal of Clinical Oncology, 1992
- A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patientsBlood, 1991
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acidThe Lancet, 1990
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitroDevelopmental Biology, 1984
- Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell linesExperimental Cell Research, 1983
- The induction of differentiation in teratocarcinoma stem cells by retinoic acidCell, 1978